Skip to main content
. 2018 Apr 3;9(4):142. doi: 10.1038/s41424-018-0013-8

Table 3.

Clinical characteristics and risk factors of IBD patients with thrombosis

CD (n = 37) UC (n = 19) p value
Sex
 Male 19 (51.4) 5 (26.3) 0.09
 Female 18 (48.6) 14 (73.7)
Oral contraceptive 3/14 (21.4) 0/15 (0)
Previous pregnancy 12/17 (70.6) 10/14 (71.4)
Abortion 4/12 (33.3) 1/10 (10)
VTE
 Inpatient 18 (48.6) 10 (50) 0.92
  Prophylaxis 14/18 (77.8) 6/7 (85.7)
 Outpatient 16/37 (45.7) 12/19 (63)
  Previous VTE 3/16 (18.7) 0
  Clinical disease activity 8/16 (50) 8/14 (57.1)
Recent hospitalization 10/36 (27.7) 6/18 (33.3)
Symptoms during VTE 26/35 (74.3) 13/19 (68.4)
 No 15 (40.5) 1(5)
Prophylaxis 14/18 (77.8) 6/7 (85.7)
Immobilization 21/37 (56.7) 12/19 (63.1) 0.78
Corticosteroid 13/37 (35.1) 10/19 (52.6) 0.26
Smoking history 11 (19.7) 5 (8.9) 0.1
 Never 22 (59.5) 11 (57.9)
 Previous 9 (24.3) 4 (21.1)
 Active 1 (2.7) 1 (5.2)
 Unknown 5 (13.5) 3 (15.8)
IBD surgery related
 Last 3 months 10/36 (27.8) 6/18 (33.3) 0.76
 At the same period of VTE 8/37(19) 3/19(16) 0.29
Catheter related 7/37(19) 3/19(16) 1.0
Familial VTE 5 (8.9) 3 (5.4) 0.47
Previous neoplasia 2 (3.6) 2 (3.6) 0.12
 At the same time of VTE 2/35 (5.7) 0
 Previous 1/35 (2.8) 1/19 (5.3)